true 0001293818 0001293818 2024-03-25 2024-03-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K/A

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

March 25, 2024
Date of Report (date of earliest event reported)

 

 

 

OpGen, Inc.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   001-37367   06-1614015

(State or other jurisdiction of
incorporation or organization)

  

(Commission
File Number)

  

(I.R.S. Employer
Identification Number)

 

9717 Key West Ave, Suite 100
Rockville, MD		   20850
(Address of principal executive offices)   (Zip code)

 

(240) 813-1260
(Registrant's telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 Title of each class

   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   OPGN   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

  

 

 

 

EXPLANATORY NOTE

 

On March 29, 2024, OpGen, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) pursuant to which the Company reported that the board of directors of the Company (the “Board”) had elected Avraham Ben-Tzvi, David Natan, and Matthew C. McMurdo to the Board, effective as of March 25, 2024. At such time, the Board had not yet appointed such directors to any committee of the Board. Accordingly, this amendment to the Initial 8-K is solely being filed for the purpose of disclosing the appointments of such directors to certain committees of the Board. This amendment adds to and does not otherwise amend or change any other disclosure contained in the Initial 8-K.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective as of May 23, 2024, the following directors were appointed to the following committees of the Board:

 

Committee:   Members:
Audit Committee:  

David Natan (Chair)

Avraham Ben-Tzvi

Matthew C. McMurdo

     
Compensation Committee  

Matthew C. McMurdo (Chair)

Avraham Ben-Tzvi

David Natan

 

Item 9.01. Financial Statements and Exhibits.

 

(d)Exhibits

 

Exhibit
Number		   Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 30, 2024 OpGen, Inc.
     
  By:

/s/ David Lazar

    Name: David Lazar
    Title: Chairman and Chief Executive Officer

 

 2 

 

v3.24.1.1.u2
Cover
Mar. 25, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description On March 29, 2024, OpGen, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) pursuant to which the Company reported that the board of directors of the Company (the “Board”) had elected Avraham Ben-Tzvi, David Natan, and Matthew C. McMurdo to the Board, effective as of March 25, 2024. At such time, the Board had not yet appointed such directors to any committee of the Board. Accordingly, this amendment to the Initial 8-K is solely being filed for the purpose of disclosing the appointments of such directors to certain committees of the Board. This amendment adds to and does not otherwise amend or change any other disclosure contained in the Initial 8-K.
Document Period End Date Mar. 25, 2024
Entity File Number 001-37367
Entity Registrant Name OpGen, Inc.
Entity Central Index Key 0001293818
Entity Tax Identification Number 06-1614015
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 9717 Key West Ave
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Rockville
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20850
City Area Code (240)
Local Phone Number 813-1260
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol OPGN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Grafico Azioni OpGen (NASDAQ:OPGN)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di OpGen
Grafico Azioni OpGen (NASDAQ:OPGN)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di OpGen